Development of a FACS-based assay for evaluating antiviral potency of compound in dengue infected peripheral blood mononuclear cells

Yilong Fu, Yen Liang Chen, Maxime Herve, Feng Gu, Pei-Yong Shi, Francesca Blasco

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Dengue fever is the most important arthropod-transmitted viral disease affecting humans. It is a blood-borne disease characterized by persistent fever and joint pain. In the blood, primary peripheral blood mononuclear cells (PBMCs), in particular monocytes, are the main target of the dengue virus (DENV). These cells are poorly permissive for in vitro dengue virus infection and their infectivity varies from donor to donor. To overcome this barrier, an anti-dengue antibody was used to improve the infectivity of DENV-2 clinical isolates to PBMCs, the monocytic leukemia cell line, THP-1 and the granulocyte cell line, KU812. A higher throughput 96-well-format assay based on a fluorescent-activated cell sorter could potentially be developed to evaluate the antiviral potency of compounds in DENV-infected PBMCs in vitro. The results correlate well with data obtained by a standard plaque assay. Altogether, an assay has been developed that enables evaluation of the antiviral activity of test compounds in a physiologically-relevant cell system (PBMCs). These screening processes are urgently needed for dengue drug discovery.

Original languageEnglish (US)
Pages (from-to)18-24
Number of pages7
JournalJournal of Virological Methods
Volume196
DOIs
StatePublished - 2014
Externally publishedYes

Fingerprint

Dengue Virus
Dengue
Antiviral Agents
Blood Cells
Virus Diseases
Cell Line
Arthropods
Hematologic Diseases
Arthralgia
Drug Discovery
Granulocytes
Monocytes
Anti-Idiotypic Antibodies
Leukemia
Fever
In Vitro Techniques

Keywords

  • Dengue
  • FACS
  • Screening

ASJC Scopus subject areas

  • Virology

Cite this

Development of a FACS-based assay for evaluating antiviral potency of compound in dengue infected peripheral blood mononuclear cells. / Fu, Yilong; Chen, Yen Liang; Herve, Maxime; Gu, Feng; Shi, Pei-Yong; Blasco, Francesca.

In: Journal of Virological Methods, Vol. 196, 2014, p. 18-24.

Research output: Contribution to journalArticle

@article{eb47ea54edce488ab8d6229d93a1d66e,
title = "Development of a FACS-based assay for evaluating antiviral potency of compound in dengue infected peripheral blood mononuclear cells",
abstract = "Dengue fever is the most important arthropod-transmitted viral disease affecting humans. It is a blood-borne disease characterized by persistent fever and joint pain. In the blood, primary peripheral blood mononuclear cells (PBMCs), in particular monocytes, are the main target of the dengue virus (DENV). These cells are poorly permissive for in vitro dengue virus infection and their infectivity varies from donor to donor. To overcome this barrier, an anti-dengue antibody was used to improve the infectivity of DENV-2 clinical isolates to PBMCs, the monocytic leukemia cell line, THP-1 and the granulocyte cell line, KU812. A higher throughput 96-well-format assay based on a fluorescent-activated cell sorter could potentially be developed to evaluate the antiviral potency of compounds in DENV-infected PBMCs in vitro. The results correlate well with data obtained by a standard plaque assay. Altogether, an assay has been developed that enables evaluation of the antiviral activity of test compounds in a physiologically-relevant cell system (PBMCs). These screening processes are urgently needed for dengue drug discovery.",
keywords = "Dengue, FACS, Screening",
author = "Yilong Fu and Chen, {Yen Liang} and Maxime Herve and Feng Gu and Pei-Yong Shi and Francesca Blasco",
year = "2014",
doi = "10.1016/j.jviromet.2013.09.009",
language = "English (US)",
volume = "196",
pages = "18--24",
journal = "Journal of Virological Methods",
issn = "0166-0934",
publisher = "Elsevier",

}

TY - JOUR

T1 - Development of a FACS-based assay for evaluating antiviral potency of compound in dengue infected peripheral blood mononuclear cells

AU - Fu, Yilong

AU - Chen, Yen Liang

AU - Herve, Maxime

AU - Gu, Feng

AU - Shi, Pei-Yong

AU - Blasco, Francesca

PY - 2014

Y1 - 2014

N2 - Dengue fever is the most important arthropod-transmitted viral disease affecting humans. It is a blood-borne disease characterized by persistent fever and joint pain. In the blood, primary peripheral blood mononuclear cells (PBMCs), in particular monocytes, are the main target of the dengue virus (DENV). These cells are poorly permissive for in vitro dengue virus infection and their infectivity varies from donor to donor. To overcome this barrier, an anti-dengue antibody was used to improve the infectivity of DENV-2 clinical isolates to PBMCs, the monocytic leukemia cell line, THP-1 and the granulocyte cell line, KU812. A higher throughput 96-well-format assay based on a fluorescent-activated cell sorter could potentially be developed to evaluate the antiviral potency of compounds in DENV-infected PBMCs in vitro. The results correlate well with data obtained by a standard plaque assay. Altogether, an assay has been developed that enables evaluation of the antiviral activity of test compounds in a physiologically-relevant cell system (PBMCs). These screening processes are urgently needed for dengue drug discovery.

AB - Dengue fever is the most important arthropod-transmitted viral disease affecting humans. It is a blood-borne disease characterized by persistent fever and joint pain. In the blood, primary peripheral blood mononuclear cells (PBMCs), in particular monocytes, are the main target of the dengue virus (DENV). These cells are poorly permissive for in vitro dengue virus infection and their infectivity varies from donor to donor. To overcome this barrier, an anti-dengue antibody was used to improve the infectivity of DENV-2 clinical isolates to PBMCs, the monocytic leukemia cell line, THP-1 and the granulocyte cell line, KU812. A higher throughput 96-well-format assay based on a fluorescent-activated cell sorter could potentially be developed to evaluate the antiviral potency of compounds in DENV-infected PBMCs in vitro. The results correlate well with data obtained by a standard plaque assay. Altogether, an assay has been developed that enables evaluation of the antiviral activity of test compounds in a physiologically-relevant cell system (PBMCs). These screening processes are urgently needed for dengue drug discovery.

KW - Dengue

KW - FACS

KW - Screening

UR - http://www.scopus.com/inward/record.url?scp=84887514075&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887514075&partnerID=8YFLogxK

U2 - 10.1016/j.jviromet.2013.09.009

DO - 10.1016/j.jviromet.2013.09.009

M3 - Article

VL - 196

SP - 18

EP - 24

JO - Journal of Virological Methods

JF - Journal of Virological Methods

SN - 0166-0934

ER -